BMI and an Anthropometry-Based Estimate of Fat Mass Percentage Are Both Valid Discriminators of Cardiometabolic Risk: A Comparison with DXA and Bioimpedance
Figure 2
Bland-Altman plots for estimates of fat mass percent (FM%): DXA versus FM%-prediction equations and bioimpedance in women.